These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22018831)

  • 1. The effect of the levonorgestrel-releasing intrauterine system, Mirena® on mast cell numbers in women with endometriosis undergoing symptomatic treatment.
    Engemise SL; Willets JM; Emembolu JO; Konje JC
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):439-42. PubMed ID: 22018831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing intrauterine system.
    Engemise SL; Willets JM; Taylor AH; Emembolu JO; Konje JC
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):101-6. PubMed ID: 21470761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium.
    Gomes MK; Rosa-e-Silva JC; Garcia SB; de Sá Rosa-e-Silva AC; Turatti A; Vieira CS; Ferriani RA
    Hum Reprod; 2009 Nov; 24(11):2736-45. PubMed ID: 19661125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system.
    Petta CA; Ferriani RA; Abrão MS; Hassan D; Rosa e Silva JC; Podgaec S; Bahamondes L
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):128-9. PubMed ID: 19181433
    [No Abstract]   [Full Text] [Related]  

  • 5. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial.
    Tanmahasamut P; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Indhavivadhana S; Leerasiri P
    Obstet Gynecol; 2012 Mar; 119(3):519-26. PubMed ID: 22314873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device.
    Haimovich S; Checa MA; Mancebo G; Fusté P; Carreras R
    Menopause; 2008; 15(5):1002-4. PubMed ID: 18451744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis.
    Matorras R; Ballesteros A; Prieto B; Ocerin I; Expósito A; Pijoan JI; Crisol L
    J Reprod Med; 2011; 56(11-12):497-503. PubMed ID: 22195333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel.
    Lockhat FB; Emembolu JE; Konje JC
    Fertil Steril; 2005 Feb; 83(2):398-404. PubMed ID: 15705381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of periostin expression in human endometrium and endometriotic lesions.
    Shen L; Liu P; Zhang P; Zhang X; Cui J
    Gynecol Endocrinol; 2012 Oct; 28(10):815-8. PubMed ID: 22471299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of mifepristone on expression of estrogen receptor and progesterone receptor in cultured human eutopic and ectopic endometria].
    Jiang J; Wu R; Wang Z
    Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):218-21. PubMed ID: 11783365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of levonorgestrel-releasing intrauterine system on endometrial estrogen and progesterone receptors in patients with endometrial hyperplasia].
    Weng M; Li L; Feng S; Xie M; Hong S
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1350-4. PubMed ID: 22985581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of progesterone and progestin on expression of regulated on activation, normal T cell expressed and secreted in eutopic endometrium from patients with endometriosis].
    Deng S; Dai Y; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L; Tan XJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):257-61. PubMed ID: 17536280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions.
    Bourlev V; Volkov N; Pavlovitch S; Lets N; Larsson A; Olovsson M
    Reproduction; 2006 Sep; 132(3):501-9. PubMed ID: 16940291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histologic examination and immunohistochemical analysis of estrogen and progesterone receptors of eutopic and ectopic endometrium in patients with endometriosis].
    Gu L; Zhang L; Gu F
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):582-5. PubMed ID: 9275449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis].
    He SM; Zhang YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1794-6. PubMed ID: 17259122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of levonorgestrel intrauterine device on human endometrial estrogen and progesterone receptors].
    Lu SM
    Zhonghua Fu Chan Ke Za Zhi; 1991 Sep; 26(5):293-4, 323. PubMed ID: 1935411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up.
    Lockhat FB; Emembolu JO; Konje JC
    Hum Reprod; 2005 Mar; 20(3):789-93. PubMed ID: 15608040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel-releasing intrauterine system: uses and controversies.
    Bahamondes L; Bahamondes MV; Monteiro I
    Expert Rev Med Devices; 2008 Jul; 5(4):437-45. PubMed ID: 18573044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.